Beijing Tongrentang is a well-known time-honored brand in the traditional Chinese medicine industry. It was founded in the eighth year of Emperor Kangxi's reign in the Qing Dynasty (1669). During its more than 300 years of history, Tongrentang people of all generations have adhered to the principle of "No matter how complicated the preparation is, they will not save labor." The traditional adage that "no matter how expensive the taste is, one must not sacrifice material resources" and the self-discipline of "cultivation, no one can see the intention but God knows it" has established the self-discipline consciousness, ensuring the long-lasting prosperity of Tongrentang's golden signature. Since the first year of Yongzheng (1721), Tongrentang has been officially entrusted to the Imperial Pharmacy of the Qing Dynasty for 188 years. It has been used by eight emperors for 188 years. It has created the rigorous spirit of Tongrentang people to be careful and strive for excellence in the pharmaceutical process. Its products are characterized by "unique formulas". , superior material selection, exquisite workmanship, and remarkable curative effect" and are well-known at home and abroad. The Tongrentang brand is well-known at home and abroad, and its advantages are unique. The Tongrentang trademark has participated in the registration of the Madrid Agreement and the Paris Convention, and is protected by international organizations. At the same time, it has gone through registration procedures in more than 50 countries and regions around the world, and the first mainland trademark was registered in Taiwan. Tong Ren Tang's famous trademarks and excellent brands have become the unique advantages of Tong Ren Tang Group's continuous development. The company's business scope: manufacturing and processing of Chinese patent medicine preparations and cosmetics, technical consulting and technical services, and the breeding and planting of medicinal animals and plants; operating Chinese patent medicines, Western medicine preparations, and biochemical drugs; self-operating and acting as an agent for the import and export of various commodities and technologies Business, except for goods and technologies that are restricted by the state or prohibited from being imported or exported. The company is a professional company that manufactures, processes and sells Chinese patent medicines. It produces about 21 dosage forms and more than 400 kinds of Chinese patent medicines annually. Its main products include Niuhuang Qingxin Pills, Angong Niuhuang Pills, Dahuoluo Pills, Guogong Liquor and other Chinese patent medicines. In the early 1990s, Tongrentang Group had hundreds of millions of yuan in loans, tens of millions of yuan in interest owed to banks, and its asset-liability ratio exceeded 70. Its production and operations were in a very difficult situation. In this situation, how to turn losses into profits? How can a century-old brand continue to survive and develop? Mei Qun introduced that in 1997, with the recognition of Tongrentang leaders, it seized the historical opportunity of shareholding reform and listing, and established Beijing Tongrentang Co., Ltd. by divesting some of its high-quality assets, raising 354 million yuan in funds, and achieving institutional and mechanistic improvements. Innovate and get out of trouble fundamentally. In 2000, it made full use of its own advantages and further increased the intensity of capital operation. It spun off Beijing Tongrentang Co., Ltd. with a high technological content and new product dosage forms of 100 million yuan to establish Beijing Tongrentang Technology Development Co., Ltd. Co., Ltd. and was listed on the Growth Enterprise Market of the Hong Kong Stock Exchange in October of the same year, raising funds of HK$240 million. It became the first company in the country to use the same state-owned assets for secondary financing and to be listed overseas. It was called the "Tongrentang model" by the securities industry ". For Tong Ren Tang, after listing, most of the high-quality assets entered the listed company, while the non-performing assets remained in the parent company, which brought a heavy burden to the parent company. On the basis of ensuring the virtuous cycle of listed companies, Tongrentang Group Company further implemented reform measures, entrusted the management of some of the group companies to two listed companies, and used the management mechanism of listed companies to transform the group companies. There have been 12 group companies Enterprises enter two listed companies. The success of the entrusted management not only created extremely favorable conditions for the parent company to escape difficulties, but also revitalized approximately 500 million yuan of existing assets. The burden of the company in the past has become a new resource and driving force for the development of the company through the transformation of the mechanism. At the same time, Tong Ren Tang has intensified its internal restructuring efforts. All the companies in the Tong Ren Tang Group have been transformed into joint stock companies or limited liability companies. Through corporate restructuring, all have achieved profitability. The successful transformation of the system and mechanism has opened up a broader horizon for the development of Tong Ren Tang. space.